Weekly Policy Blog: Colorado’s 2024 Legislative Session Wraps Up  

Colorado’s 2024 legislative session, the Second Regular Session of the 74th General Assembly, concluded on May 8, the 120th day of session. During the final weeks of session, the Colorado BioScience A...

Learn More

Weekly Policy Blog: HB24-1446 Supports Professional Development for Science Teachers 

HB24-1446, a bill that supports professional development for science teachers, has passed the General Assembly and will soon be sent to Governor Polis for his signature. The bill provides funding for...

Learn More

Weekly Policy Blog: CBSA Advocates on Federal Issues During the BIO Fly-In 

Colorado Bioscience Association (CBSA) Vice President and Counsel for Policy + Advocacy, Amy Goodman, represented the Colorado life sciences ecosystem and advocated for community priorities on Capitol...

Learn More

Weekly Policy Blog: Grants and Tax Credits Support Colorado’s Advanced Industries 

Two of the Capital + Growth programs supporting efforts to position Colorado as America’s epicenter for talent, investors, and life sciences-centric companies looking to start, relocate, or expand in...

Learn More

Weekly Policy Blog: Amgen Lawsuit Asserts Colorado PDAB is Unconstitutional   

On March 22, Amgen, the maker of the autoimmune disease drug Enbrel, filed a lawsuit against the Colorado Prescription Drug Affordability Board (PDAB or Board) in the U.S. District Court for the Distr...

Learn More

Weekly Policy Blog: Colorado Drug Importation Program Faces Roadblocks  

Colorado is still working to become the second state, after Florida, to be authorized to import prescription drugs from Canada. The Colorado Department of Health Care Policy & Financing (HCPF) sub...

Learn More

Weekly Policy Blog: EPA Releases Final Rule for EtO Sterilization Facilities 

On March 14, the Environmental Protection Agency (EPA) released its update to the National Emission Standards for Hazardous Air Pollutants (NESHAP) final rule for ethylene oxide (EtO) commercial steri...

Learn More

Weekly Policy Blog: Campaign & Legislation Support Colorado’s Drive to Be a Leading Life Sciences Hub 

Colorado BioScience Association and a consortium of 22 Colorado partners have launched Colorado Hub for Health Impact, a new national economic development campaign to position Colorado as America’s ep...

Learn More

Weekly Policy Blog: CBSA’s 2024 Day at the Capitol 

CBSA held its annual Day at the Capitol event on February 28. CBSA members, legislators, and legislative staff first gathered for a health innovation company showcase and networking, which highlighted...

Learn More

Weekly Policy Blog: PDAB Initiates Upper Payment Limit Rulemaking Process for the First Time 

On Friday, February 23, the Colorado Prescription Drug Affordability Board (PDAB or Board) decided to initiate an “upper payment limit” (UPL) rulemaking process for the autoimmune disease drug Enbrel...

Learn More